| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8ef8778881967fa92628e2754b4649d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-57 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
1997-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f217ad57a3edc5d536e5f23bb90e167d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00b03969e059c3b0c6a9118185f23b20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e126f075204ad89dcd8f2126dde0183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_860e183b858d2e0817b6094da4d0cc7a |
| publicationDate |
1999-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0904090-A1 |
| titleOfInvention |
Egg anti-inflammatory composition, method of isolation and use |
| abstract |
The invention is directed to an anti-inflammatory composition obtained from the eggs of an avian that has been hyperimmunized with one or more antigens, and, in particular, bacterial antigens. The invention is further directed to an egg or egg product comprising effective amounts of the anti-inflammatory composition. The invention is also directed to a method for isolating the anti-inflammatory composition. The invention is finally directed to methods of treating inflammation using the anti-inflammatory composition and/or egg or egg products comprising effective amounts of the anti-inflammatory composition. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013053503-A1 |
| priorityDate |
1996-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |